Sarepta turns to Duke’s CRISPR work for next-gen DMD therapies – FierceBiotech
|
Sarepta turns to Duke’s CRISPR work for next-gen DMD therapies
FierceBiotech Sarepta says it will collaborate with Gersbach’s lab to “advance the CRISPR platform and take the lead on clinical development.” It’s signed a series of similar deals, including in gene therapy, to help it create better, broader treatments for the … |
News-Medical.net |
Gene therapy prevents age-related learning and memory problems in mice
News-Medical.net Researchers from the Institute of Neurosciences at the Universitat Autònoma de Barcelona (INc-UAB) and the Vall d’Hebron Research Institute (VHIR) are the first to demonstrate that regulation of the brain’s Klotho gene using gene therapy protects … |
News-Medical.net |
Gene therapy prevents age-related learning and memory problems in mice
News-Medical.net Researchers from the Institute of Neurosciences at the Universitat Autònoma de Barcelona (INc-UAB) and the Vall d’Hebron Research Institute (VHIR) are the first to demonstrate that regulation of the brain’s Klotho gene using gene therapy protects … |
News-Medical.net |
Gene therapy prevents age-related learning and memory problems in mice
News-Medical.net Researchers from the Institute of Neurosciences at the Universitat Autònoma de Barcelona (INc-UAB) and the Vall d’Hebron Research Institute (VHIR) are the first to demonstrate that regulation of the brain’s Klotho gene using gene therapy protects … |
News-Medical.net |
Gene therapy prevents age-related learning and memory problems in mice
News-Medical.net Researchers from the Institute of Neurosciences at the Universitat Autònoma de Barcelona (INc-UAB) and the Vall d’Hebron Research Institute (VHIR) are the first to demonstrate that regulation of the brain’s Klotho gene using gene therapy protects … |
News-Medical.net |
Gene therapy prevents age-related learning and memory problems in mice
News-Medical.net Researchers from the Institute of Neurosciences at the Universitat Autònoma de Barcelona (INc-UAB) and the Vall d’Hebron Research Institute (VHIR) are the first to demonstrate that regulation of the brain’s Klotho gene using gene therapy protects … |